iKEY Announces New Line of Infection-Control Keyboards to Protect Patients
AUSTIN, Texas -- Keyboard manufacturer iKEY says it believes healthcare professionals should be confident that the treatment they provide isn't making patients sicker. In response, iKEY has developed the FL Series of cleanable medical keyboards and mouse that are designed to reduce cross contamination.
"Patient care is the number one priority for the medical community," said iKEY spokesperson Alaine Anhalt. "As a nurse, you have an innate drive to help others and care for them in times of crisis. Yet how would you feel knowing that you are a source of infection that is killing 90,000 patients annually?"
The recent shift to electronic records has helped spread MRSA and other drug-resistant bugs to the nearly 2 million patients that suffer hospital-acquired infections annually. Laboratory tests have proved that keyboards contaminate the gloved fingers of a nurse who can then transfer MRSA, VRE and other deadly bugs to other patients. The average keyboard contains 3,295-germs/square inch, while a toilet seat contains only 49.
iKEY's new FL Series features even lower-profile silicon rubber keys for easy cleaning and a new light grey color scheme that matches other hospital equipment.
In October 2004, BallStateUniversity conducted tests on behalf of iKEY to test whether their SlimKey-MD medical keyboard could be disinfected of MRSA and how it withstands a hospital bleach solution. The final results showed zero growth of MRSA, VRE and various bloodborne pathogens after cleaning and the keyboard continued to work flawlessly in the succeeding hours.
Source: iKEY
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
